Literature DB >> 2139073

Soluble factor-independent stimulation of human B cell response by mouse thymoma cells. Cyclosporine A-resistant and -sensitive cell contact signals.

X H Zhang1, C Hauser, R H Zubler.   

Abstract

In a Th cell-dependent antibody response, the Th act on B cells partly via a helper activity that is cell contact-dependent and cyclosporine A (CsA)-resistant. This activity seems to be required to induce responsiveness of the B cells toward T cell-derived soluble factors (cytokines) generally believed to be essential for B cell proliferation as well as for Ig secretion. In our study, we have investigated a system in which human B cells are stimulated by mutant EL-4 thymoma cells of mouse origin. It was found that human B cells proliferate and secrete Ig (either 1) in the presence of EL-4 cells plus human T cell supernatant (T-SUP), or 2) in the presence of EL-4 cells alone which have been induced with PMA or IL-1. The first situation conformed to the known synergy between CsA-resistant Th signal and cytokines. However, the B response due to PMA-induced EL-4 cells was special. The PMA-inducible helper activity was CsA-sensitive at the same CsA concentration that inhibited IL-2 secretion of EL-4 cells, but the murine factors in EL-4 supernatant had no effect on human B cells; the helper effect did not occur across a semipermeable membrane. Any contribution of soluble factors from contaminating human T cells was ruled out by adding single human B cells by flow microfluorimetry to cultures with EL-4 cells and PMA. Such B cells generated clonal IgM, IgG, and/or IgA responses. CsA, thus, interfered with some cell contact-mediated signal. However, CsA did not reduce the amount of LFA-1 molecules on EL-4 cells. In conclusion, EL-4 cells can induce proliferation and differentiation of human B cells in a soluble factor-independent manner, via CsA-resistant and CsA-sensitive helper activities. This may represent an alternative pathway of B cell activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139073

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Frequencies of HIV-reactive B cells in seropositive and seronegative individuals.

Authors:  R H Zubler; L H Perrin; A Doucet; X Zhang; Y P Huang; P A Miescher
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

Review 2.  Regulation of IgE production and other immunopathogenetic mechanisms.

Authors:  B A Chowdhury
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 3.  Regulation of IgE synthesis: from the membrane to the genes.

Authors:  D Vercelli; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Efficient generation of monoclonal antibodies from preselected antigen-specific B cells. Efficient immortalization of preselected B cells.

Authors:  P G Steenbakkers; H A Hubers; A W Rijnders
Journal:  Mol Biol Rep       Date:  1994-03       Impact factor: 2.316

5.  IL-4 and transforming growth factor-beta suppress human immunoglobulin secretion in vitro by surface IgD- B cells.

Authors:  C Ninomiya; H L Spiegelberg
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

6.  Are cord blood B cells functionally mature?

Authors:  A Tucci; A Mouzaki; H James; J Y Bonnefoy; R H Zubler
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization.

Authors:  C Heard; P Brams; E Walsh; T Huynh; S Chamat; M Reff; A Owyang; W Shestowsky; R Newman
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

8.  CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.

Authors:  J Kwekkeboom; M De Boer; J M Tager; C De Groot
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

9.  Similar CD40 ligand expression on EL-4 thymoma cell lines with widely different helper activity for B lymphocytes.

Authors:  C Werner-Favre; J F Gauchat; G Mazzei; J P Aubry; J Y Bonnefoy; R H Zubler
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.